FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements von Bekaii-Saab, TS, Valle, JW, Cutsem, EV, Rimassa, L, Furuse, J, Ioka, T, Melisi, D, Macarulla, T, Bridgewater, J, Wasan, H, Borad, MJ, Abou-Alfa, GK, Jiang, P, Lihou, CF, Zhen, H, Asatiani, E, Féliz, L, Vogel, A

Volltext bestellen